Hospital-acquired neonatal bacterial meningitis: the impacts of cefotaxime usage on mortality and of amikacin usage on incidence.

Annals of Tropical Paediatrics
Y M CoovadiaJ van den Ende

Abstract

All cases of bacterial meningitis in the neonatal unit at King Edward VIII Hospital, Durban for the period 1 January 1981 to 31 December 1987 were reviewed. In particular, we looked at the impact of cefotaxime on mortality rates and amikacin on the incidence of hospital-acquired Gram-negative bacillary (GNB) meningitis. Klebsiella was found to be the commonest cause of neonatal meningitis, followed by Escherichia coli and Streptococcus agalactiae. Eighty-four per cent of all cases of GNB meningitis presented more than 3 days after birth, with the vast majority being caused by gentamicin-resistant Klebsiella. A decline in the incidence of meningitis from 1.27/1000 live births in 1981 and 0.95/1000 for the period 1981-1986 to 0.22/1000 live births in 1987, with no cases of Klebsiella meningitis being seen in that year, coincided with the exclusive use of amikacin as the parenteral aminoglycoside in place of gentamicin in the unit after August 1986. The initial decline in the incidence of meningitis from 0.93/1000 in 1985 to 0.46/1000 in 1986 was attributed to the introduction in 1985 of strict hand disinfection measures to prevent cross-infection in the unit. The case mortality rate (CMR) fell from 0.65 for the period 1981-1984 t...Continue Reading

References

Aug 1, 1976·Pediatric Clinics of North America·R D Feigin, P R Dodge
May 7, 1977·The Medical Journal of Australia·B R Lewis, J M Gupta
May 1, 1987·The Pediatric Infectious Disease Journal·T J FeldsteinT A Larson
Mar 1, 1985·The Medical Clinics of North America·R H Meade
Apr 1, 1973·The Journal of Pediatrics·G H McCracken
Feb 1, 1968·Pediatric Clinics of North America·A W Mathies, P F Wehrle
Dec 1, 1982·The Journal of Hospital Infection·R Hurley
Sep 1, 1984·The Journal of Infection·C J Mulder, H C Zanen
Jul 1, 1984·Acta paediatrica Scandinavica·A C LongeA A Okolo
Mar 12, 1981·The New England Journal of Medicine·J D Siegel, G H McCracken
Aug 14, 1958·The New England Journal of Medicine·M ZIAI, R J HAGGERTY
Jun 1, 1961·The New England Journal of Medicine·R V GROOVERB H LANDING

❮ Previous
Next ❯

Citations

Mar 15, 2011·Tropical Medicine & International Health : TM & IH·J S FurykE Molyneux
Apr 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alemnew F DagnewSue Ann Costa Clemens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Related Papers

South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie
T E MadibaJ John
The American Journal of Medicine
R J MangiV T Andriole
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
P M JeenaE Gouws
© 2022 Meta ULC. All rights reserved